Bruker Daltonics to Present at the International Mass Spectrometry Conference (IMSC) in Prague on Clinical Proteomics, MALDI Imaging, Ion Trap ETD, FTMS and Metabolomics
PRAGUE, Czech Republic--(BUSINESS WIRE)--Aug. 26, 2006--
At the 2006 International Mass Spectrometry Conference, Bruker Daltonics will make numerous presentations on mass spectrometry applications in proteomics and clinical research solutions, as well as in small molecule analysis and metabolomics. On Tuesday, August 29, 2006, top Bruker Daltonics scientists will lead in-depth discussions of the following topics at a luncheon seminar from 1:15 to 2:15 (...)
Bruker BioSciences Reports Solid Revenue Growth and Improved Earnings in Second Quarter 2006
BILLERICA, Mass.--(BUSINESS WIRE)--Aug. 1, 2006--Bruker BioSciences Corporation (NASDAQ: BRKR) today reported second quarter 2006 results. On July 1, 2006, Bruker BioSciences completed its acquisition of Bruker Optics Inc. Due to the Laukien family majority ownership of both companies, this acquisition is required to be accounted for as a pooling of interests. As a result of this accounting treatment, all historical periods will be restated beginning in (...)
Health Discovery Announces Non-Exclusive Worldwide Licensing Agreement with Bruker Daltonics
SAVANNAH, Ga.--(BUSINESS WIRE)--Aug. 1, 2006--
New Capability Assists Researchers and Pharmaceutical Firms in Biomarker Discovery and Validation, Discovering Drug Targets, and Personalized Medicine
Health Discovery Corporation ("HDC") today announced that it has executed a non-exclusive worldwide license agreement with Bruker Daltonics Inc. covering Bruker Daltonics' use of HDC's Support Vector Machine ("SVM") technology in the ClinProTools(TM) (...)
Bruker Daltonics and Isis Pharmaceuticals Enter Into Manufacturing and Distribution Agreement for Ibis T5000 Biosensor System
BILLERICA, Mass. and CARLSBAD, Calif., July 31 /PRNewswire-FirstCall/ --
Bruker Daltonics, a subsidiary of Bruker BioSciences (Nasdaq: BRKR), and Isis Pharmaceuticals (Nasdaq: ISIS) announce today a strategic alliance for manufacturing and distribution of Isis' Ibis T5000(TM) biosensor system. The Ibis T5000, developed by Isis' Ibis Biosciences(TM) division, is a universal biosensor system that can simultaneously identify thousands of types of (...)
Bruker BioSciences Corporation to Release Second Quarter 2006 Financial Results on August 1, 2006
BILLERICA, Mass.--(BUSINESS WIRE)--July 26, 2006--
Bruker BioSciences Corporation (NASDAQ:BRKR) plans to release its second quarter financial results on Tuesday, August 1, 2006 after the market closes. Bruker BioSciences will then host an operator-assisted earnings conference call the following morning, Wednesday, August 2, at 9 a.m. Eastern Time, 6 a.m. Pacific Time. To listen to the webcast, investors can go to www.bruker-biosciences.com and click on (...)
Bruker BioSciences Announces Closing of Acquisition of Bruker Optics
BILLERICA, Mass.--(BUSINESS WIRE)--July 5, 2006--
Bruker BioSciences Corporation (NASDAQ: BRKR) announces today that on July 1st, 2006 it closed the acquisition of molecular spectroscopy company Bruker Optics Inc. for $135 million, payable approximately 59% in cash and 41% in BRKR stock. Approximately 11.4 million new Bruker BioSciences shares were issued for the stock component of the purchase consideration. The number of Bruker BioSciences shares (...)
Bruker BioSciences Shareholders Approve Acquisition of Bruker Optics; Combined Company to Be a Leading Provider of Molecular Analysis Solutions to the Life Science, Materials Research, Homeland Security and Industrial Markets
BILLERICA, Mass.--(BUSINESS WIRE)--June 29, 2006--
Bruker BioSciences Corporation (NASDAQ: BRKR) announces after the Company's Annual Meeting today that its shareholders have approved the acquisition of molecular spectroscopy company Bruker Optics Inc. for $135 million, to be paid approximately 59% in cash and 41% in BRKR stock. The acquisition agreement had previously received unanimous approval by a Special Committee of independent directors of the (...)
Bruker Daltonics Launches RAID-AFM and RAID-S2 for Long-Term Chemical Monitoring in Homeland Security and Defense Infrastructure Protection
TAMPERE, Finland--(BUSINESS WIRE)--June 20, 2006--
The NBC Detection Business of Bruker Daltonik GmbH, based in Leipzig, Germany, today announces the RAID(TM)-AFM and the RAID(TM)-S2, two new stationary chemical detectors, at the NBC 2006 Symposium on Chemical, Biological, Nuclear and Radiological Threats in Tampere, Finland.
For over 15 years, Bruker Daltonics has been recognized as a leading expert in chemical detection applications of ion mobility (...)
Bruker Daltonics and Protein Discovery Announce MALDI Molecular Imaging Mass Spectrometry Co-Marketing Agreement
BILLERICA, Mass. & KNOXVILLE, Tenn.--(BUSINESS WIRE)--May 30, 2006--
Bruker Daltonics Inc. and Protein Discovery, Inc. announce today that they intend to collaborate on introducing scientists to the protein biomarker discovery capabilities of MALDI molecular imaging mass spectrometry. Protein Discovery holds a license from Vanderbilt University to provide imaging mass spectrometry services, and provides these services to customers in the research, (...)
Bruker Daltonics Announces World's First Refrigerated 15 Tesla FTMS Magnet with New Tools for Top-down Protein Characterization
SEATTLE, May 28, 2006 (BUSINESS WIRE) -- At the 2006 ASMS conference, Bruker Daltonics today announces new tools to accelerate the detailed top-down characterization of proteins using the Company's apex(R)-Qe line of hybrid Fourier Transform mass spectrometers (Q-q-FTMS). These top-down tools include the world's first 15.0 Tesla (T) refrigerated (R-series) FTMS magnet, along with a novel and proprietary method of charge deconvolution, based on maximum (...)
